AUGUST 13, 2020
Grants Awarded

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
In the spotlight
From Developmental Therapeutics and Translational and Clinical Research
Multi-PI, inter-programmatic, $3.1M R01 awarded by the National Cancer Institute (NCI) to Raoul Kopelman, Ph.D. and Xeuding Wang, Ph.D., for “Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME).”

From Cancer Genetics
From Developmental Therapeutics
Russell Ryan, M.D., $1.8M NCI R01 for “Identifying Functional Drivers of MYC Activation via Developmental Enhancers in Diffuse Large B-cell Lymphoma.”
Joshi Alumkal, M.D., $1.2M Department of Defense (DoD) Peer Reviewed Prostate Cancer Research Program, Idea Development Award for “Targeting LSD1 in Neuroendocrine Prostate Cancer.”
From Cancer Biology



Kyoung Lee, Ph.D., $562K DoD Peer Reviewed Cancer Research Program, Career Development Award for “B cells in Pancreatic Tumorigenesis.”
Other $100K+ Extramural Grants Awarded in July
NCI

Alexey Nesvizhskii, Ph.D.: T32 Renewal ($1.7M) “Proteogenomics of Cancer Training Program” (CB)

Jennifer Jimenez (mentor: Costas Lyssiotis, Ph.D.): F31 ($113K) for “Defining the Role of Menin in the Ewing Sarcoma Stress Response” (CB) 

Kenneth Trieu (mentor: Sunny Wong, Ph.D.): F31 ($113K) for “Characterizing Genetic Factors that Modulate Stage-Specific Basal Cell Carcinoma Tumorigenesis” (CB)

Andrea Pesch (mentor: Corey Speers, M.D., Ph.D.): F31 ($112K) for “Elucidating the Mechanism of CDK4/6 Inhibitor-Mediated Radiosensitization of ER+ Breast Cancers” (TACR)

Other NIH

Carole Parent, Ph.D., and Phyllis Hanson, M.D., Ph.D.: NIAID R01 ($2.6M) for “Signal Relay During Directed Cell Migration” (CB)

Duxin Sun, Ph.D., and Irina Grigorova, Ph.D.: NIAID R01 ($2.6M) for “Virus-Like Nanoparticles for Non-Capsid Antigen Delivery with Virus Structure/Functional Mimicry to Activate B Cell Immunity” (DT)

Cheong-Hee Chang, Ph.D.: NIAID R01 ($2.5M) for “Regulation of Metabolic Pathways in NKT Cells” (CHI)

Sriram Chandrasekaran, Ph.D.: NIGMS R35 ($1.8M) for “Linking Metabolic Activity with Drug Sensitivity Using Metabolic Influence Networks” (CG)

Elizabeth Gensterblum-Miller (mentor: Chad Brenner, Ph.D.): NIDCR F31 ($113K) for “Analysis of the E7-Mediated Mechanism of MHC Class I Repression in HNSCC” (TACR)

Other External

Renny Franceschi, Ph.D.: $1.2M DoD Peer Reviewed Medical Research Program Investigator-Initiated Research Award for “Novel Strategy for Bone Tissue Engineering Using Nanofibrous Osteogenic Collagen Peptides” (CB)

Marcin Cieslik, Ph.D.: $224K from Innovation in Cancer Informatics for “Translational Tools and Resources to Advance MHC (HLA) Cancer Genetics” (CB)
Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | BLOG michiganhealthlab.org